Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179308 · ClinicalTrials.gov registry record · NA
Regional Anesthesia and Lung Cancer Recurrence
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT01179308 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 67 participants.
The verdict
NCT01179308, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
Test the effect of combined regiona/general anesthesia on lung cancer recurrence compared to general anesthesia alone.
Interventions
- OTHER General-epidural anesthesia
- OTHER Balanced general anesthesia and postoperative opioids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01179308
The ClinicalTrials.gov registry entry for NCT01179308 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which General-epidural anesthesia is the first listed.
NCT01179308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01179308 about?
NCT01179308 is a clinical study titled "Regional Anesthesia and Lung Cancer Recurrence". Test the effect of combined regiona/general anesthesia on lung cancer recurrence compared to general anesthesia alone.
What is the current status of trial NCT01179308?
This trial is currently terminated. It is a NA study. The enrollment target is 67 participants. The study started on 2010-08. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01179308?
The interventions under investigation include: General-epidural anesthesia (OTHER), Balanced general anesthesia and postoperative opioids (OTHER).
Who is sponsoring clinical trial NCT01179308?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.